DACARBAZINE for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 83 adverse event reports in the FDA FAERS database where DACARBAZINE was used for Malignant melanoma.
Most Reported Side Effects for DACARBAZINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 501 | 9.8% | 50 | 335 |
| Off label use | 471 | 9.2% | 120 | 159 |
| Neutropenia | 400 | 7.8% | 48 | 163 |
| Drug ineffective | 261 | 5.1% | 50 | 54 |
| Pyrexia | 245 | 4.8% | 25 | 184 |
| Neuropathy peripheral | 239 | 4.7% | 8 | 28 |
| Product use in unapproved indication | 219 | 4.3% | 65 | 70 |
| Disease progression | 204 | 4.0% | 33 | 17 |
| Nausea | 203 | 4.0% | 23 | 123 |
| Anaemia | 186 | 3.6% | 20 | 64 |
| Vomiting | 158 | 3.1% | 27 | 105 |
| Sepsis | 156 | 3.1% | 80 | 92 |
| Diarrhoea | 154 | 3.0% | 35 | 104 |
| Second primary malignancy | 154 | 3.0% | 81 | 35 |
| Thrombocytopenia | 153 | 3.0% | 19 | 57 |
Other Indications for DACARBAZINE
Hodgkin's disease (3,178)
Product used for unknown indication (343)
Lymphoma (81)
Neuroblastoma (81)
Chemotherapy (72)
Hodgkin's disease stage iv (55)
Hodgkin's disease nodular sclerosis (50)
Metastatic malignant melanoma (47)
Hodgkin's disease stage ii (44)
Leiomyosarcoma (42)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)